This inventor holds 2 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1989-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1991
Title: Celebrating Innovations by Inventor Yoshie Sakamoto
Introduction: Yoshie Sakamoto, an accomplished inventor based in Yonago, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a focus on developing new therapeutic agents, she is recognized for her innovative work and has been granted a total of two patents related to her discoveries.
Latest Patents: Sakamoto's latest patents include her work on N-containing heterocyclic compounds and a composition comprising the same. Her first patent relates to a pharmaceutical composition intended as a therapeutic agent for ischemic disease. This patent features a compound that is characterized by a formula involving carbamoyl and ureido substitutions with variations of alkyl groups. Her second patent focuses on morpholine-containing pyridine compounds. This compound also includes a structure with various optional substitutions, expanding the potential therapeutic applications in the industry.
Career Highlights: Currently, Yoshie Sakamoto is associated with Fujisawa Pharmaceutical Company, Ltd., where she applies her expertise in drug development and innovation. Her dedication to advancing medical science through her inventions has positioned her as a notable figure in her field.
Collaborations: Throughout her career, Sakamoto has collaborated with esteemed colleagues such as Takao Takaya and Hisashi Takasugi. These collaborations have enriched her innovative pursuits, allowing for a dynamic exchange of ideas within the realm of pharmaceutical research.
Conclusion: In conclusion, Yoshie Sakamoto stands out as a talented inventor whose work is deeply rooted in creating impactful pharmaceutical solutions. Through her patents and collaborations, she continues to make strides in the industry, underscoring the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
